Close

Saneca Pharma receives confirmation of multi-dosage cGMP approval for Russia

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Role of CDMOs in Outsourced Pharmaceutical Manufacturing

The pharmaceutical sector stands at the crossroads of innovation...

Regional Pharma Hubs for Effective Supply Chain Outcomes

It is well to be noted that the pharmaceutical...

Incorporation of Antimicrobial Coatings in Pharmaceuticals

In the very rapidly evolving pharmaceutical spectrum, the safeguarding...

Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia.

The company achieved this cGMP certification following an inspection by the Federal State Institution ‘State Institute of Drugs and Good Practices’ of Russia.

As one of the first European CDMOs to be successful in meeting the new inspection requirements of the Russian authorities, the approval marks another milestone for Saneca Pharma as it strengthens the scope of its pharmaceutical development and manufacturing services to the region.

Commenting on the certification, Anthony Sheehan, CEO at Saneca Pharma, said: “We are delighted to have successfully completed this recent inspection. Russia is a key market for Saneca Pharma, forming an important part of our growth strategy. The certification demonstrates our commitment to meeting the needs of our growing client base in the country, while supporting customers in achieving compliance with various global regulatory authorities.

“Russia’s importance to the pharmaceutical producers in Central and Eastern Europe is being increasingly recognised, with significant year-on-year revenue growth. Successfully passing this inspection is a challenging process for companies and it is a testament to both the expertise of our team, our quality systems and the condition of our manufacturing facilities that we have been successful in meeting the standards required.”

The certification covers the manufacture and packaging of hard and soft gel capsules, liquids for external use, semi-solids such as ointments and film coated tablets.

Based in western Slovakia, with close proximity to Vienna, Saneca Pharma offers its customers strong capabilities in solids, semi-solids and liquids, as well as specialist expertise in the development and manufacture of opiate APIs and finished dosage forms from farm to pharmacy.

For further information on Saneca Pharma, visit www.saneca.com

 

Latest stories

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Role of CDMOs in Outsourced Pharmaceutical Manufacturing

The pharmaceutical sector stands at the crossroads of innovation...

Regional Pharma Hubs for Effective Supply Chain Outcomes

It is well to be noted that the pharmaceutical...

Incorporation of Antimicrobial Coatings in Pharmaceuticals

In the very rapidly evolving pharmaceutical spectrum, the safeguarding...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back